What is Kronox Lab Sciences Ltd. Quarterly Revenue?

Kronox Lab Sciences Ltd. Quarterly Revenue Kronox Lab Sciences Jun-2026 Quarterly Revenue is Rs 30 Cr which is growth of 18.0% YoY.

What is Kronox Lab Sciences Ltd. Quarterly Net Profit?

Kronox Lab Sciences Ltd. Quarterly Net Profit Kronox Lab Sciences Jun-2026 Quarterly Net Profit is Rs 7 Cr which is growth of 16.3% YoY.

What is Kronox Lab Sciences Ltd. Annual Revenue?

Kronox Lab Sciences Ltd. Annual Revenue Kronox Lab Sciences Mar-2026 Annual Revenue is Rs 106 Cr which is growth of 3.6% YoY.

What is Kronox Lab Sciences Ltd. Annual Net Profit?

Kronox Lab Sciences Ltd. Annual Net Profit Kronox Lab Sciences Mar-2026 Annual Net Profit is Rs 28 Cr which is growth of 8.6% YoY.

What is Kronox Lab Sciences Ltd. Total Shareholders Fund?

Kronox Lab Sciences Ltd. Total Shareholders Fund Kronox Lab Sciences Mar-2026 Total Shareholders Fund is Rs 116 Cr which is growth of 28.9% YoY.

What is Kronox Lab Sciences Ltd. Total Assets?

Kronox Lab Sciences Ltd. Total Assets Kronox Lab Sciences Mar-2026 Total Assets is Rs 128 Cr which is growth of 29.0% YoY.

What is Kronox Lab Sciences Ltd. Book Value Per Share?

Kronox Lab Sciences Ltd. Book Value Per Share Kronox Lab Sciences Mar-2026 Book Value Per Share is 31 Rs which is growth of 28.9% YoY.

What is Kronox Lab Sciences Ltd. ROE?

Kronox Lab Sciences Ltd. ROE Kronox Lab Sciences Mar-2026 ROE is 24% which is growth of 4.4% YoY.

What is Kronox Lab Sciences Ltd. Cash From Operating Activity?

Kronox Lab Sciences Ltd. Cash From Operating Activity Kronox Lab Sciences Mar-2026 Cash From Operating Activity is Rs 24 Cr which is growth of -22.2% YoY.

What is Kronox Lab Sciences Ltd. Net Cash Flow?

Kronox Lab Sciences Ltd. Net Cash Flow Kronox Lab Sciences Mar-2026 Net Cash Flow is Rs -0 Cr which is growth of -164.3% YoY.

Kronox Lab Sciences Ltd.

NSE: KRONOX | BSE: 544187

Mid-range Performer

Download real time

3.32(1.71%)

105.94% Gain from 52W Low

23,446

NSE+BSE Volume

NSE 03 Nov, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Board Meeting

The next board meeting for Kronox Lab Sciences is on 05 Nov 2026 for the purpose of Quarterly Results See details

Kronox Lab Sciences quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Kronox Lab Sciences quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Kronox Lab Sciences Jun-2026 Quarterly Revenue is Rs 30 Cr which is growth of 18.0% YoY.
POSITIVE
Quarterly Net Profit Kronox Lab Sciences Jun-2026 Quarterly Net Profit is Rs 7 Cr which is growth of 16.3% YoY.

Kronox Lab Sciences Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
TOTAL_SR_Q Total Rev. ⌄	29.7	28.3	26.4	26.6	25.2	27.1	24.8	25.2	25.6	23	21.1	21.1	26.2
SR_Q Operating Rev.	28.4	26.1	25.3	25.5	24.3	26.1	24	24.9	25.2	22.2	20.7	21	26
OI_Q Other Income	1.3	2.2	1.1	1	0.9	0.9	0.8	0.4	0.4	0.8	0.4	0.1	0.2
OEXPNS_Q Operating Exp.	19.4	16.6	17.3	16.9	16.3	18.4	15.7	16.1	17	14.3	14.4	15.4	17.4
OEXPNS_Q Operating Exp.	19.4	16.6	17.3	16.9	16.3	18.4	15.7	16.1	17	14.3	14.4	15.4	17.4
OP_Q Operating Profit	9	9.5	8	8.7	8	7.8	8.4	8.8	8.2	7.9	6.3	5.6	8.5
OPMPCT_Q Operating Profit Margin %	31.70%	36.44%	31.75%	33.86%	32.81%	29.66%	34.84%	35.42%	32.58%	35.44%	30.46%	26.80%	32.82%
DEP_Q Depr.	0.5	0.7	0.5	0.5	0.4	0.4	0.4	0.3	0.3	0.3	0.3	0.4	0.3
INT_Q Interest	0	0	0	0
PBT_Q Profit Before Tax	9.8	11	8.6	9.2	8.4	8.3	8.8	8.8	8.3	8.4	6.4	5.4	8.4
TAX_Q Tax	2.5	3	2	2.5	2.2	2	2.3	2.4	2.2	2.5	1.6	1.1	2.1
NP_Q Net Profit	7.3	8	6.6	6.7	6.3	6.3	6.5	6.5	6.2	5.9	4.8	4.3	6.4
EPS_adj_Q EPS Adj. latest	2	2.2	1.8	1.8	1.7	1.7	1.8	1.7	1.7	1.6	1.3	1.1	1.7
NP_TTM Net profit TTM	28.6	27.6	25.9	25.8	25.6	25.5	25	23.4	21.1	21.4	17.9	-	-
EPS_TTM Basic EPS TTM	7.7	7.4	7	7	6.9	6.9	6.8	6.3	5.7	5.8	4.8	-	-
results_pdf Results PDF
result_notes Result Notes	Notes	Notes	Notes	Notes	Notes		Notes	Notes	Notes

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Kronox Lab Sciences competitor comparison and performance snapshot within industry

Kronox Lab Sciences annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Kronox Lab Sciences Mar-2026 Annual Revenue is Rs 106 Cr which is growth of 3.6% YoY.
POSITIVE
Annual Net Profit Kronox Lab Sciences Mar-2026 Annual Net Profit is Rs 28 Cr which is growth of 8.6% YoY.

Kronox Lab Sciences Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21
SR_A Total Rev. Ann. ⌄	3%	11%	110.9	106.4	102.7	91.4	97.5	83.3	63.2
TotalOperatingRevenues_A Operating Rev. Ann.	1.9%	10.1%	105.3	101.2	100.2	89.9	95.6	82.3	62.5
OI_A Other Income Ann.	39.9%	45.4%	5.6	5.2	2.5	1.6	1.9	1.1	0.8
OEXPNS_A Operating Exp. Ann.	-3.1%	7%	70.1	67	67.1	61.5	73.6	62.6	47.7
OEXPNS_A Operating Exp. Ann.	-3.1%	7%	70.1	67	67.1	61.5	73.6	62.6	47.7
OP_A Operating Profit Ann.	16%	18.3%	35.2	34.3	33.1	28.3	22	19.7	14.8
OPMPCT_A OPM Ann. %	12.6%	6.6%		32.21%	32.25%	30.97%	22.56%	23.63%	23.41%
TotalExpenses_A Total Exp. Ann. ⌄	-2.8%	6.7%		69.1	68.5	62.8	75.2	65	50
OtherExpenses_A Other Exp. Ann.	3.6%	10.5%	13.7	13	11.4	9.5	11.7	9.4	7.9
EmployeeBenefitExpenses_A Employee Exp. Ann.	1.9%	6.5%	7.6	7.4	4.8	6.2	7	5.8	5.4
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	18.2%	20.4%		39.5	35.7	29.9	23.9	20.8	15.6
EBIDTPCT_A EBITDA Ann. margin %	14.8%	8.5%		37.09%	34.71%	32.70%	24.53%	24.94%	24.64%
INT_A Interest Ann.	0%	-24.2%	0.1	0.1			0.1	0.4	0.4
DEP_A Depr.	11.9%	1%	2.1	2.1	1.4	1.3	1.5	2	2
PBT_A PBT Ann.	18.7%	23.1%	38.6	37.3	34.3	28.6	22.3	18.4	13.2
TAX_A Tax Ann.	19%	22.4%	10	9.6	8.8	7.3	5.7	4.7	3.5
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	18.6%	23.4%		27.7	25.5	21.4	16.6	13.6	9.7
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-		-	-	-	-	-	-
NP_A Net Profit Ann.	18.6%	23.4%	28.6	27.7	25.5	21.4	16.6	13.6	9.7
NETPCT_A NPM Ann. %	16.3%	11.9%		27.32%	25.41%	23.75%	17.38%	16.56%	15.57%
EPS_adj_A EPS Adj. latest Ann.	18.6%	23.6%		7.5	6.9	5.8	4.5	3.7	2.6
result_notes Result Notes				Notes
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

3.6%

2Y CAGR

7.9%

3Y CAGR

5Y CAGR

11%

Total Revenue Annual growth is stable compared to historical averages.

Net Profit Ann.

1Y CHG

8.6%

2Y CAGR

13.8%

3Y CAGR

18.6%

5Y CAGR

23.4%

Net Profit Annual growth is lower than historical averages.

Operating Exp. Ann.

1Y CHG

-0.1%

2Y CAGR

4.4%

3Y CAGR

-3.1%

5Y CAGR

Operating Expenses Annual Cr is falling faster than historical averages.

Kronox Lab Sciences balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Kronox Lab Sciences Mar-2026 Total Shareholders Fund is Rs 116 Cr which is growth of 28.9% YoY.
POSITIVE
Total Assets Kronox Lab Sciences Mar-2026 Total Assets is Rs 128 Cr which is growth of 29.0% YoY.

Kronox Lab Sciences Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	37.5%	34.1%	116.1	90.1	66.3	44.7	40.4	26.8
EQCAP_A Equity Share Capital Ann.	0%	184.2%	37.1	37.1	37.1	37.1	0.2	0.2
TotalShareCapital_A Total Share Capital Ann.	0%	184.2%	37.1	37.1	37.1	37.1	0.2	0.2
ReservesAndSurplus_A Reserves Plus Surplus Ann.	118.2%	24.3%	79	53	29.2	7.6	40.1	26.6
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	118.2%	24.3%	79	53	29.2	7.6	40.1	26.6
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	26%	-19.2%	1	0	0	0.5	2.7	2.9
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	-	-
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	-	-					1.7	2.7
CL_A Total Current Liabilities Ann. ⌄	5.3%	5.7%	10.4	8.7	7.7	8.9	13.8	7.9
TradePayables_A Trade Payables Ann.	-5.4%	0%	6.6	7.3	6.2	7.8	11.5	6.6
OtherCurrentLiabilities_A Other Current Liabilities Ann.	89%	19.7%	2.7	0.9	0.8	0.4	1.5	1.1
ShortTermProvisions_A ST Provisions Ann.	-5.9%	10.8%	0.5	0.5	0.6	0.6	0.6	0.3
TL_A Total Capital Plus Liabilities Ann.	33.2%	27.6%	127.5	98.8	74	54	56.8	37.7
FixedAssets_A Fixed Assets Ann. ⌄	23%	25.3%	29.6	28.6	26.9	15.9	11.3	9.6
TangibleAssets_A Tangible Assets Ann.	21.8%	25.6%	28.7	27.9	26.4	15.9	11.3	9.2
IntangibleAssets_A Intangible Assets Ann.	-	-
CapitalWorkInProgress_A Capital Work In Progress Ann.	-	17.6%	0.9	0.8	0.5			0.4
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	34.8%	33.7%	48.7	35.5	27.4	19.9	12.6	11.4
NonCurrentInvestments_A Non Current Investments Ann.	-	-	0	0	0	0	0	0
DeferredTaxAssets_A Deferred Tax Assets Ann.	10.1%	14.9%	0.4	0.4	0.4	0.3	0.3	0.2
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-	-
OtherNonCurrentAssets_A Other Non Current Assets Ann.	72.9%	63.3%	18.6	6.5	0.1	3.6	1	1.6
CA_A Total Current Assets Ann. ⌄	32.1%	24.6%	78.8	63.3	46.6	34.2	44.2	26.2
CurrentInvestments_A Current Investments Ann.	-	-
TradeReceivables_A Trade Receivables Ann.	4.5%	6.6%	21.2	19.9	17.7	18.6	25.8	15.4
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	138.3%	87.5%	48.7	8.4	3.6	3.6	2.8	2.1
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	-	-
OtherCurrentAssets_A Other Current Assets Ann.	-40.9%	-28.5%	0.6	28.6	16.1	2.9	8	3.2
TA_A Total Assets Ann.	33.2%	27.6%	127.5	98.8	74	54	56.8	37.7
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	-	-		2.6	0.2
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	-53.5%	-	3.7	3.7	3.7	36.9
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	-	-	0	0	0	0	0	0
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-	-

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

29%

2Y CAGR

31.3%

3Y CAGR

33.2%

5Y CAGR

27.6%

Total Assets Annual growth is stable compared to historical averages.

Total Current Liabilities Ann.

1Y CHG

19.5%

2Y CAGR

16.2%

3Y CAGR

5.3%

5Y CAGR

5.7%

Total Current Liabilities Annual Cr growth is higher than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

28.9%

2Y CAGR

32.3%

3Y CAGR

37.5%

5Y CAGR

34.1%

Total ShareHolders Funds Annual growth is lower than historical averages.

Kronox Lab Sciences ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Kronox Lab Sciences Mar-2026 Book Value Per Share is 31 Rs which is growth of 28.9% YoY.
POSITIVE
ROE Kronox Lab Sciences Mar-2026 ROE is 24% which is growth of 4.4% YoY.

Kronox Lab Sciences Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21
BVSH_A BVSH Ann.	37.7%	-51%	31.3	24.3	17.9	12	1,674.4	1,112.6
ROA_A RoA Ann. %	-11%	-3.4%	21.69%	25.76%	28.85%	30.75%	23.99%	25.84%
ROE_A ROE Ann. %	-13.8%	-8.1%	23.81%	28.26%	32.20%	37.19%	33.76%	36.28%
ROCE_A ROCE Ann. %	-13.7%	-7%	31.93%	38.02%	43.13%	49.63%	43.60%	45.79%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	15.9%	9.3%	38.98%	35.58%	33.26%	25.02%	25.27%	24.94%
PBITMargin_A EBIT Ann. Margin %	16.4%	11.2%	36.96%	34.20%	31.83%	23.45%	22.80%	21.77%
PBTMargin_A PBT Ann. Margin %	16.4%	11.7%	36.85%	34.20%	31.83%	23.35%	22.31%	21.16%
NETPCT_A NPM Ann. %	16.3%	11.9%	27.32%	25.41%	23.75%	17.38%	16.56%	15.57%
ASETTO_A Asset Turnover Ann. %	-19.1%	-	0.9	1.2	1.4	1.7	1.7	-
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	24.9%	18.2%	7.6	7.3	6.1	3.9	3.2	3.3
QuickRatio_A Quick Ratio Ann.	34.4%	21.2%	6.8	6.6	4.9	2.8	2.7	2.6
DividendPayoutNP_A Dividend Payout to NP Ann.	-	-	0.1	0.1		-	-	-
EarningRetention_A Earning Retention Ann. %	-	-	93.30%	92.73%
CashEarningRetention_A Cash Earning Retention Ann. %	-	-	93.77%	93.10%
CashEarningRetention_A Cash Earning Retention Ann. %	-	-	93.77%	93.10%
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	-	-	315	525.3
EVPerNetSales_A EV Per Net Sales Ann.	-	-	3.1	5.2	-	-	-	-
PBV_A Price To Book Value Adjusted	-27.3%	103.7%	6.32	9.51	11.06	16.42	0.12	0.18
EVPerEBITDA_A EV Per EBITDA Ann.	-	-	8	14.7	-	-	-	-
MarketCapPerSales_A Market Cap Per Sales Ann.	-	-	3.6	5.3	-	-	-	-
RetentionRatios_A Retention Ratio Ann. %	-	-	93.29%	92.72%
EYield_A Earnings Yield Ann.	-	-	0.1	0.1
DEBT_CE_A Total Debt to Total Equity Ann.			0				0

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

-15.7%

2Y CAGR

-14%

3Y CAGR

-13.8%

5Y CAGR

-8.1%

ROE Annual % is falling faster than historical averages.

RoA Ann. %

1Y CHG

-15.8%

2Y CAGR

-13.3%

3Y CAGR

-11%

5Y CAGR

-3.4%

RoA Annual % is falling faster than historical averages.

Current Ratio Ann.

1Y CHG

4.1%

2Y CAGR

11.6%

3Y CAGR

24.9%

5Y CAGR

18.2%

Current Ratio Annual growth is lower than historical averages.

Kronox Lab Sciences cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Cash From Operating Activity Kronox Lab Sciences Mar-2026 Cash From Operating Activity is Rs 24 Cr which is growth of -22.2% YoY.
NEGATIVE
Net Cash Flow Kronox Lab Sciences Mar-2026 Net Cash Flow is Rs -0 Cr which is growth of -164.3% YoY.

Kronox Lab Sciences Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21
CFO_A Cash from Operating Act. Ann. ⌄	6.7%	16.2%	23.9	30.7	17.4	19.7	9	11.3
PBT_A PBT Ann.	18.7%	23.1%	37.3	34.3	28.6	22.3	18.4	13.2
INT_A Interest Ann.	0%	-24.2%	0.1			0.1	0.4	0.4
TAX_A Tax Ann.	19%	22.4%	9.6	8.8	7.3	5.7	4.7	3.5
CFI_A Cash from Investing Act. Ann.	-	-	-23.8	-28.4	-17.3	-5.5	-7.6	-3
CFA_A Cash from Financing Act. Ann.	-	-	-0.4	-1.9		-13.4	-0.7	-7.1
NCF_A Net Cash Flow Ann. ⌄	-	-	-0.3	0.5	0.1	0.8	0.8	1.3
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	2.3%	30.3%	3	2.6	2.5	2.8	2.1	0.8
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	-8%	5.9%	2.8	3	2.6	3.6	2.8	2.1

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

-22.1%

2Y CAGR

17.2%

3Y CAGR

6.7%

5Y CAGR

16.2%

Cash from Operating Activity Annual is falling faster than historical averages.

Kronox Lab Sciences investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents

Kronox Lab Sciences quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents